Search Within

Clifford Hudis

Formats
  1. Journal Article (484)
  2. Meeting Abstract (393)
  3. Book Section (15)
  4. Conference Paper (10)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Breast Medicine Service (906)
  2. Department of Medicine (906)
  3. Solid Tumor Oncology Division (906)
  4. Survivorship Research (906)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (318)
  6. Epidemiology and Biostatistics (242)

More Groups

People
  1. Larry Norton (293)
  2. Sujata Patil (141)
  3. Andrew Seidman (116)
  4. Chau Dang (111)
  5. Maura Dickler (102)
  6. Tiffany Traina (95)

More People

Years
  1. 2025 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (246)
  2. Cancer Research (108)
  3. Breast Cancer Research and Treatment (77)
  4. Clinical Cancer Research (33)
  5. Cancer (30)
  6. Annals of Oncology (29)

More Publications

Publishers
  1. American Society of Clinical Oncology (249)
  2. American Association for Cancer Research (163)
  3. Springer (100)
  4. Elsevier Inc. (84)
  5. Oxford University Press (55)
  6. Wiley Blackwell (45)

More Publishers

Results (906)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Serum creatinine (Cr) values in patients with metastatic breast cancer (MBC) treated with pamidronate (PAM) administered as an intravenous 1 hour infusion (1 h)
    Meeting Abstract

    Van Poznak, C.; Ben-Porat, L.; Panageas, K.; Leone, D.; Seidman, A.; Hudis, C.
    Bone (2002)

    Fulltext@MSK | Save
  • Effects of exemestane and raloxifene on breast density by mammography and MRI in postmenopausal women: Preliminary data from a pilot chemoprevention trial
    Meeting Abstract

    Dickler, M.; Morris, E.; Robson, M.; Choi, J.; Hummer, A.; Panageas, K.; Ballon, D.; Borgen, P.; Norton, L.; Hudis, C.
    Cancer Epidemiology Biomarkers and Prevention (2002)

    Fulltext@MSK | Save
  • The cyclooxygenase-2 inhibitor celecoxib protects against HER2/neu-induced breast cancer
    Meeting Abstract

    Howe, L. R.; Subbaramaiah, K.; Patel, J.; Masferrer, J. L.; Deora, A.; Hudis, C.; Thaler, H. T.; Muller, W. J.; Du, B. H.; Brown, A. M. C.; more...
    Cancer Epidemiology Biomarkers and Prevention (2002)

    Fulltext@MSK | Save
  • Bone mineral density and hormone receptor status in patients with newly diagnosed breast cancer, a retrospective assessment
    Meeting Abstract

    Van Poznak, C. H.; Howard, J. E.; Seidman, A. D.; Norton, L.; Hudis, C.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Impact of tamoxifen on the risk of metachronous contralateral breast cancer in women with germline mutations of BRCA1 or BRCA2
    Meeting Abstract

    Robson, M. E.; Satagopan, J.; Hudis, C. A.; Boyd, J.; Offit, K.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Effect of creatinine clearance (CrCl) on patterns of toxicity in breast cancer (BC) patients (pts) age 65 and older receiving adjuvant chemotherapy
    Meeting Abstract

    Hurria, A.; Panageas, K.; Brogan, K.; Norton, L.; Howard, J.; Hudis, C.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Final report: Epoetin alfa maintains hemoglobin levels and quality of life in breast cancer patients during conventional adjuvant chemotherapy
    Meeting Abstract

    Hudis, C.; Williams, D.; Gralow, J.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Incidence of amenorrhea (A) in breast cancer (BC) patients (pts) <= 40 years of age after paclitaxel (T)-based adjuvant chemotherapy (CT)
    Meeting Abstract

    Fornier, M. N.; Modi, S.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) correlates with HER2 status by immunohistochemistry (IHC) and fluorescent in-situ hybridization (FISH) in metastatic breast cancer (MBC) patients (pts) treated with weekly (W) trastuzumab (H) and paclitaxel (T)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Schwartz, M. K.; Panageas, K. S.; Norton, L.; Hudis, C. A.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Open-label, phase II, multicenter trial of ZD1839 ('Iressa') in patients with advanced breast cancer
    Meeting Abstract

    Albain, K.; Elledge, R.; Gradishar, W. J.; Hayes, D. F.; Rowinsky, E.; Hudis, C.; Pusztai, L.; Tripathy, D.; Modi, S.; Rubi, S.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save